Techub News: DeSci platform BIO Protocol announces an upgrade to the BioXP system and launches PeptAI token sale. This upgrade allows USDC holders to participate in Ignition Sales, and BIO holders can mint BioXP to gain priority. Currently, the PeptAI sale has oversubscribed by 12.9 times, with over 650 participants contributing more than 610k USDC. PeptAI is an autonomous agent-driven peptide drug discovery platform capable of running nine discovery processes. According to the roadmap, the project plans to complete its first on-chain wet lab certification through Molecule Labs in the second quarter of this year, enabling autonomous agent delegation and full on-chain verification of experimental processes.

BIO-6.59%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin